Japan’s AGC Makes Agreed €240m Bid For MolMed

Silvio Berlusconi’s Fininvest holds 23% in the cancer-focused biotech

 
• By Sten Stovall
M&A
AGC wants to catch clinical-stage Italian biotech MolMed • Source: Shutterstock

More from Business

More from Scrip